Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Total Liabilities (2016 - 2025)

Tandem Diabetes Care's Total Liabilities history spans 13 years, with the latest figure at $725.9 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 3.03% year-over-year to $725.9 million; the TTM value through Dec 2025 reached $725.9 million, up 3.03%, while the annual FY2025 figure was $725.9 million, 3.03% up from the prior year.
  • Total Liabilities reached $725.9 million in Q4 2025 per TNDM's latest filing, down from $741.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $766.9 million in Q1 2025 to a low of $440.9 million in Q1 2021.
  • Average Total Liabilities over 5 years is $626.3 million, with a median of $625.8 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: surged 223.8% in 2021, then increased 0.03% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $472.0 million in 2021, then rose by 29.83% to $612.8 million in 2022, then rose by 4.27% to $639.0 million in 2023, then grew by 10.26% to $704.6 million in 2024, then rose by 3.03% to $725.9 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Total Liabilities are $725.9 million (Q4 2025), $741.7 million (Q3 2025), and $742.5 million (Q2 2025).